Bank of New York Mellon
LHDX

Bank of New York Mellon’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bank of New York Mellon’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,935
Closed -$290K – 4504
2021
Q1 		$290K Buy
+23,935
New +$475K ﹤0.01% 3922

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JCM
JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of New York Mellon's LHDX Position: Q2 2021 in Review

Bank of New York Mellon sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 23,935 shares — an estimated $290K sold.

Bank of New York Mellon first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $290K in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

  • Bank of New York Mellon reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 23,935 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $290K.
  • Bank of New York Mellon first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Bank of New York Mellon's Lucira Health, Inc. Common Stock position peaked at $290K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.